Tanja Rehling

Mrs. Tanja Rehling

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
LPLucas Henrique Figueiredo Prates
Lucas Henrique Figueiredo Prates
JFJakob Fiebig
Jakob Fiebig
HSHenrik Schlosser
Henrik Schlosser
ELEleni Liapi
Eleni Liapi
TRTanja Rehling
Tanja Rehling
IHIrina Haecker
Irina Haecker
In this study, we report the complexities and challenges associated with achieving robust RNA interference (RNAi)-mediated gene knockdown in the mosquitoes Aedes aegypti and Aedes albopictus, a pivotal approach for genetic analysis and vector control. Despite RNAi’s potential for species-specific gene targeting, our independent efforts to establish oral delivery of RNAi for identifying genes critical for mosquito development and fitness encountered significant challenges, failing to reproduce previously reported potent RNAi effects. We independently evaluated a range of RNAi-inducing molecules (siRNAs, shRNAs, and dsRNAs) and administration methods (oral delivery, immersion, and microinjection) in three different laboratories. We also tested various mosquito strains and utilized microorganisms for RNA delivery. Our results reveal a pronounced inconsistency in RNAi efficacy, characterized by minimal effects on larval survival and gene expression levels in most instances despite strong published effects for the tested targets. One or multiple factors, including RNase activity in the gut, the cellular internalization and processing of RNA molecules, and the systemic dissemination of the RNAi signal, could be involved in this variability, all of which are barely understood in mosquitoes. The challenges identified in this study highlight the necessity for additional research into the underlying mechanisms of mosquito RNAi to develop more robust RNAi-based methodologies. Our findings emphasize the intricacies of RNAi application in mosquitoes, which present a substantial barrier to its utilization in genetic control strategies.

Verified
Journal Article
Open access
PDF file
IHIrina Haecker
Irina Haecker
TRTanja Rehling
Tanja Rehling
HSHenrik Schlosser
Henrik Schlosser
DMDaniela Mayorga-Ch
Daniela Mayorga-Ch
MHMara Heilig
Mara Heilig
MSMarc F Schetelig
Marc F Schetelig
Creating transgenic insects is a key technology in insect genetics and molecular biology. A widely used instrument in insect transgenesis is the piggyBac transposase, resulting in essentially random genomic integrations. In contrast, site-specific recombinases allow the targeted integration of the transgene construct into a specific genomic target site. Both strategies, however, often face limitations due to low transgenesis efficiencies. We aimed to enhance transgenesis efficiencies by utilizing capped mRNA as a source of transposase or recombinase instead of a helper plasmid. A systematic comparison of transgenesis efficiencies in Aedes mosquitoes, as models for hard-to-transform insects, showed that suppling piggyBac transposase as mRNA increased the average transformation efficiency in Aedes aegypti from less than 5% with the plasmid source to about 50% with mRNA. Similar high activity was observed in Ae. albopictus with pBac mRNA. No efficiency differences between plasmid and mRNA were observed in recombination experiments. Furthermore, a hyperactive version of piggyBac transposase delivered as a plasmid did not improve the transformation efficiency in Ae. aegypti or the agricultural pest Drosophila suzukii. We believe that the use of mRNA has strong potential for enhancing piggyBac transformation efficiencies in other mosquitoes and important agricultural pests, such as tephritids.

7 July 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
RARoswitha A. Aumann
Roswitha A. Aumann
GGGeorgia Gouvi
Georgia Gouvi
MGMaria-Eleni Gregoriou
Maria-Eleni Gregoriou
TRTanja Rehling
Tanja Rehling
GSGermano Sollazzo
Germano Sollazzo
MSMarc F Schetelig
Marc F Schetelig
The Sterile Insect Technique (SIT) is a species-specific and environmentally friendly method for effectively controlling pest insect populations based on releasing reared, sterile insects into infested areas. Sex sorting in rearing facilities, enabling male-only releases, is necessary to ensure SIT programs are efficient, cost-effective and, in case of mosquito control, also safe. This can be greatly facilitated by genetic sexing strains (GSS), exhibiting sex-specific phenotypic markers. However, the development of GSS remains challenging. The construction of a temperature-sensitive lethal ( tsl )-based GSS in the Mediterranean fruit fly ( Ceratitis capitata ) over three decades ago was considered a major breakthrough for SIT programs but was never successfully replicated in other pests. After over 30 y of research, we have pinpointed a specific mutation in the C. capitata lysine--tRNA ligase ( Lysyl-tRNA synthetase , LysRS ) gene responsible for the tsl phenotype. Introducing this specific mutation into a wild-type strain produced full embryonic lethality under heat stress, replicating the original mutant phenotype. The random integration of a LysRS minigene reversed this effect. The high conservation of LysRS among insects suggests that tsl-based GSS could be expanded to multiple pest species and extend applications of SIT programs for disease prevention and the protection of agriculture.

1 September 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
IHIrina Haecker
Irina Haecker
TRTanja Rehling
Tanja Rehling
HSHenrik Schlosser
Henrik Schlosser
DMDaniela Mayorga-Churion
Daniela Mayorga-Churion
MHMara Heilig
Mara Heilig
MSMarc F Schetelig
Marc F Schetelig
Creating transgenic insects is a key technology in insect genetics and molecular biology. A widely used instrument in insect transgenesis is the piggyBac transposase, resulting in essentially ran-dom genomic integrations. In contrast, site-specific recombinases allow the targeted integration of the transgene construct into a specific genomic target site. Both strategies, however, often face limitations due to low transgenesis rates. We aimed to enhance transgenesis rates by utilizing a capped mRNA as a source of transposase or recombinase instead of a helper plasmid. A system-atic comparison of transgenesis rates in Aedes mosquitoes, as models for hard to transform in-sects, showed that suppling piggyBac transposase as mRNA increased the average transfor-mation efficiency in Aedes aegypti from less than 5% with the plasmid source to about 50% with mRNA. Similar high transformation activity was observed in Ae. albopictus with pBac mRNA. No efficiency differences between plasmid and mRNA were observed in recombination experi-ments. Furthermore, a codon-optimized version of piggyBac transposase delivered as plasmid didn’t improve the transformation efficiency in Ae. aegypti or the agricultural pest D. suzukii. We believe that the use of mRNA has strong potential for enhancing pBac transformation efficiencies in other mosquitoes and important agricultural pests such as tephritids.

4 December 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EREdwin Ramírez-Santos
Edwin Ramírez-Santos
PRPedro Rendón
Pedro Rendón
KBKostas Bourtzis
Kostas Bourtzis
MSMarc F Schetelig
Marc F Schetelig
CCCarlos Cáceres
Carlos Cáceres
PLPablo Liedo
Pablo Liedo
The transgenic strain of the Mediterranean fruit fly (medfly), Ceratitis capitata (Wied.) VIENNA 8 1260, developed from the classical genetic sexing strain VIENNA 8, has two molecular markers that exhibit red fluorescence in the body and green fluorescence in testicles and sperm. These traits offer a precise tool to discriminate between mass-reared sterile males and wild fertile males, and they could potentially increase the effectiveness of control programs for this pest. To assess the risk of horizontal transfer of the fluorescence transgenes in natural ecosystems, we used the VIENNA 8 1260 strain and the medfly parasitoid Fopius ceratitivorus. The fluorescence signal and the inheritance of the fluorescence gene markers were monitored for over 16 generations (about two years) in both species using fluorescence microscopy and a PCR-based assay. The PCR analysis was performed in four independent laboratories. Both fluorescence microscopy and PCR analysis indicated that no horizontal gene transfer of the DsRed transgene occurred during 16 generations of medfly parasitoid rearing under experimental conditions.

6 April 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TRTanja Rehling
Tanja Rehling
KMKim Mentchen
Kim Mentchen
LKLeonie Konopka
Leonie Konopka
WOWiebke Obermann
Wiebke Obermann
FWFriedemann Weber
Friedemann Weber
FMFrancesca Magari
Francesca Magari
Arthropod-borne viruses cause major global health burdens, yet few vaccines or antivirals exist. Targeting host factors required for viral replication offers a promising approach. The DEAD-box RNA helicase eIF4A, a core component of the translation initiation complex eIF4F, unwinds structured 5′ UTRs and is therefore critical also for the translation of many viral RNAs. The compound classes rocaglates and pateamines are potent eIF4A inhibitors in mammalian cells. Here we show that the natural rocaglate silvestrol strongly inhibits Rift Valley fever virus replication (RVFV) in human cells without cytotoxicity, expanding the list of eIF4A-dependent arboviruses. Moreover, we studied eIF4A function and rocaglate/pateamine sensitivity in insects, specifically in the arboviral vector Aedes aegypti and the fruit flies Anastrepha suspensa and Drosophila melanogaster . Sequence analysis showed conservation of the rocaglate-binding motif between the human eIF4A and all three insects. Dual luciferase assays in insect cell lines confirmed selective translation inhibition from purine-rich reporters by silvestrol below cytotoxic thresholds. Purified eIF4A variants from all three insect species retained helicase activity, allowing direct testing of inhibitor interactions. Thermal shift assays demonstrated robust stabilization of eIF4A–RNA complexes by both compound classes in the wildtype proteins, with unexpected rocaglate sensitivity of the putatively insensitive Ae. aegypti H161L mutant, indicating a unique binding pocket geometry of the mosquito protein. In summary, our results present RVFV as another drug target for eIF4A inhibitors and highlight comparative biochemistry studies providing insights into distinctive eIF4A inhibitor binding site architecture, with the prospect of exploring informed design to develop species-specific inhibitors.